UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054359
Receipt number R000061833
Scientific Title A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin
Date of disclosure of the study information 2024/05/10
Last modified on 2025/05/11 09:10:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin

Acronym

A Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin

Scientific Title

A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin

Scientific Title:Acronym

A Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin

Region

Japan


Condition

Condition

Type 2 diaebtes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Measuring metal-related parameters in patients with and without metformin treatment to elucidate the changes in metal dynamics in patients with type 2 diabetes taking metformin.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Comparing serum copper levels in patients with type 2 diabetes with and without metformin.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Metformin Treatment Group:
1. Diagnosed with type 2 diabetes at the time of registration.
2. Aged 18 years or older.
3. Has been continuously taking metformin for at least six months at the time of registration.
4. Has provided written informed consent for participation in this study.

Control Group: Non-Metformin Users:
1. Diagnosed with type 2 diabetes at the time of registration.
2. Aged 18 years or older.
3. Has not been taking metformin continuously for at least six months at the time of registration.
4. Has provided written informed consent for participation in this study.

Key exclusion criteria

1. Patients currently taking iron supplements.
2. Patients currently taking zinc supplements.
3. Patients currently taking vitamin B12 supplements.
4. Patients currently taking folic acid supplements.
5. Patients with anemia.
6. Patients who have undergone gastric, duodenal, or small intestine resection (excluding those who have undergone endoscopic mucosal resection or submucosal dissection).
7. Patients who are pregnant or breastfeeding.
8. Patients with malabsorption issues (e.g., chronic pancreatitis, inflammatory bowel disease, malabsorption syndrome).
9. Patients with renal dysfunction (eGFR < 30 mL/min/1.73m2).
10. Patients with cirrhosis.
11. Patients currently undergoing treatment for malignant tumors.
12. Other patients deemed inappropriate for the study by the investigator.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Kazuhiko
Middle name
Last name Sakaguchi

Organization

Kobe University Graduate School of Medicine

Division name

Division of Diabetes and Endocrinology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-5861

Email

kzhkskgc@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Natsu
Middle name
Last name Otowa-Suematsu

Organization

Kobe University Graduate School of Medicine

Division name

Division of Diabetes and Endocrinology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-5861

Homepage URL


Email

suematsu@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Manpei Suzuki Diabetes Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital Clinical and Translational Research Center

Address

7-5-2 Kusunokichou, Chuo-ku, Kobe, Japan

Tel

078-382-6669

Email

kansatsu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

199

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 06 Month 01 Day

Date of IRB

2022 Year 07 Month 20 Day

Anticipated trial start date

2022 Year 07 Month 20 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cross-sectional observational study


Management information

Registered date

2024 Year 05 Month 10 Day

Last modified on

2025 Year 05 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061833